Adynxx

Developer of oligonucleotide technology for developing chronic pain management drugs

placeSan Francisco, California, United States calendar_todayFounded 2007 groups7 employees language adynxx.com

Registered entities

Investor mix

4 investors on record; lead investors include TPG.

Investor typeCountShare
Venture capital125%
Private equity125%
Other / undisclosed250%
Coming soon